Michael T. McCaul
Price Movement Since Trade
How each stock has moved from the trade date to the most recent close.
Suspicious Timing Detected
5 flagsMichael T. McCaul bought $1,000,001-$5,000,000 in $HUM (HUMANA INC) on 2025-05-19, 1 day before S1816 ("Improving Seniors’ Timely Access to Care Act of 2025") was introduced, which mandates electronic prior authorization for Medicare Advantage plans.
Michael T. McCaul bought $1,000,001-$5,000,000 in $HUM (HUMANA INC) on 2025-05-28, 23 days before HR4056 ("RAMP Act") was introduced, a bill aiming to reduce legal exposure for non-group health insurers in Medicare secondary payer cases.
Michael T. McCaul bought $1,000,001-$5,000,000 in $UNH (UNITEDHEALTH GROUP INC) on 2025-05-20, 31 days before HR4056 ("RAMP Act") was introduced, a bill aiming to reduce legal exposure for non-group health insurers in Medicare secondary payer cases.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | Other | LLM FAMILY INVESTMENTS LP(Other) | $1,000,001-$5,000,000 | — | — | — | May 7, 2025 |
| BUY | Other | RECURRING CAPITAL FUND IV LP(Other) | $1,000,001-$5,000,000 | — | — | — | May 7, 2025 |
| BUY | $NUE | NUCOR CORPORATION | $1,000,001-$5,000,000 | $120.12 | $214.25 | +78.4% | May 12, 2025 |
| BUY | Other | GREATER ORLANDO AVTN AT(Other) | $1,000,001-$5,000,000 | — | — | — | May 21, 2025 |
| BUY | $SWK | STANLEY BLACK & DECKER | $1,000,001-$5,000,000 | $70.62 | — | — | May 19, 2025 |
| BUY | Government Securities | TENNESSEE ST GO BDS B(Government Securities) | $1,000,001-$5,000,000 | — | — | — | May 9, 2025 |
| BUY | $UNH | UNITEDHEALTH GROUP INC | $1,000,001-$5,000,000 | $321.58 | — | — | May 20, 2025 |
| BUY | $LPX | LOUISIANA-PAC Corp Com | $1,000,001-$5,000,000 | $93.44 | — | — | May 15, 2025 |
| BUY | $MRK | MERCK AND CO INC SHS | $1,000,001-$5,000,000 | $77.23 | $111.86 | +44.8% | May 19, 2025 |
| BUY | $HUM | HUMANA INC | $1,000,001-$5,000,000 | $247.34 | — | — | May 19, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
No Surprises Act Enforcement Act
The No Surprises Act Enforcement Act (HR4710) is an early-stage House bill that would increase balance billing penalties from $100/day to $10,000 per violation for health insurers. The bill has been referred to three committees and has a Senate companion (S2420). Despite the bearish legislative signal, major insurers including ELV (+7.71% 7-day) and HUM (+13.29% 7-day) have shown strong recent price momentum driven by other factors.
State-Based Universal Health Care Act of 2025
HR4406 is in very early legislative stages—referred to five committees with 34 cosponsors. No funding is authorized. The bill is not a near-term market factor for any healthcare company.
H.R. 1 — Budget Reconciliation Act (One Big Beautiful Bill)
H.R. 1 signed into law July 4, 2025, with agricultural and defense titles that structurally benefit ADM via stabilized commodity pricing and GD via authorized shipbuilding growth. However, 10 months post-enactment, market price action for both stocks (ADM +7.89% 7-day to $74.69; GD +9.59% 7-day to $343.24) is detached from this legislation, indicating other factors dominate.
Improving Seniors’ Timely Access to Care Act of 2025
The Improving Seniors' Timely Access to Care Act mandates electronic prior authorization for all Medicare Advantage plans by 2028, forcing a regulatory-driven health IT spending wave. Oracle (ORCL) is the clearest beneficiary as dominant EHR vendor, while major MA insurers (UNH, ELV, HUM, CVS) face mandated IT investment but gain long-term operational efficiency. The bill has strong bipartisan momentum with 68 cosponsors and an identical House companion.
Supporting Healthy Moms and Babies Act
The 'Supporting Healthy Moms and Babies Act' (HR3762) is an early-stage bill that would mandate comprehensive maternity/newborn care coverage without cost-sharing under ACA plans. With 28 cosponsors, a companion bill in the Senate, and referral to three committees, legislative progress is early but has nominal bipartisan support. Insurers UNH and CI face increased medical costs, while diagnostic labs LH and DGX benefit from higher utilization. No dollar amount is authorized or appropriated.
Association Health Plans Act
S.1847 is an early-stage bill expanding self-funded association health plans for small businesses, structurally negative for fully insured commercial carriers. The bill has no dollar authorization and remains in committee with only 6 sponsors — near-term passage probability is low. Real market data shows large health insurers (UNH, HUM, CVS, CNC) surging 15-55% in the last 30 days, but this rally is unrelated to S.1847 and driven by broader sector dynamics.
Medical Research for Our Troops Act
HR3906 (Medical Research for Our Troops Act) would restore $1.181B in military medical research funding, but the bill has been stalled in the House Appropriations Committee since June 2025 with zero legislative movement. Real market data shows healthcare stocks declining 3-8% over 30 days due to broader sector headwinds, not this bill. No actionable trade signal exists.
Affordable Housing Equity Act of 2025
HR3964, the Affordable Housing Equity Act of 2025, is an early-stage bill that would increase the eligible basis for LIHTC projects serving extremely low-income households to 150%. It has been referred to the House Ways and Means Committee with only one cosponsor, indicating negligible near-term passage probability. No direct market impact is expected; the bill's effects on homebuilders and lenders are structural and contingent on future legislative progress.
RAMP Act
The RAMP Act (HR4056) is an early-stage bill that would restrict the Medicare Secondary Payer private right of action to group health plans only, granting legal relief to auto, liability, workers' compensation, and no-fault insurers. The bill is referenced to two committees and has only one cosponsor, indicating a long legislative path. For the named insurers—UnitedHealth, Cigna, Humana—the bill is largely neutral as they primarily operate group health plans, which retain existing litigation exposure.
ADAPT Act
The ADAPT Act (S2356) is a zero-funding authorization bill that would expand Medicare/Medicaid/CHIP coverage to include supervised psychology trainees. It remains in early committee stage with minimal support. Recent rallies in UNH, HUM, and CVS (+41.6%, +35.86%, +15.55% over 30 days) are driven by unrelated factors such as the April 18 Executive Order on psychedelic therapies, not this bill. No actionable market impact.
Other Filings by Michael T. McCaul
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.